Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702721 | 12570272 | 1 | I | 20160213 | 20160706 | 20160719 | 20160719 | EXP | FR-PFIZER INC-2016333219 | PFIZER | 61.00 | YR | M | Y | 90.00000 | KG | 20160719 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702721 | 12570272 | 1 | PS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, DAILY | Y | 12151 | 25 | MG | FILM-COATED TABLET | ||||||
| 125702721 | 12570272 | 2 | SS | Triatec | RAMIPRIL | 1 | Oral | 5 MG, DAILY | Y | 19901 | 5 | MG | |||||||
| 125702721 | 12570272 | 3 | SS | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 1 G, DAILY | Y | 0 | 1 | G | TABLET | ||||||
| 125702721 | 12570272 | 4 | SS | ESIDREX | HYDROCHLOROTHIAZIDE | 1 | 50 MG, DAILY | Y | 0 | 50 | MG | TABLET | |||||||
| 125702721 | 12570272 | 5 | C | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | CAPSULE | BID | ||||||
| 125702721 | 12570272 | 6 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | FILM-COATED TABLET | QD | ||||||
| 125702721 | 12570272 | 7 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID | ||||||
| 125702721 | 12570272 | 8 | C | ARANESP | DARBEPOETIN ALFA | 1 | Oral | 80 UG EVERY 15 DAYS | 0 | 80 | UG | ||||||||
| 125702721 | 12570272 | 9 | C | ROVALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | 450 MG, ALTERNATE DAY | 0 | 450 | MG | FILM-COATED TABLET | QOD | ||||||
| 125702721 | 12570272 | 10 | C | NEORAL | CYCLOSPORINE | 1 | Oral | 30 MG, 2X/DAY | 0 | 30 | MG | CAPSULE, SOFT | BID | ||||||
| 125702721 | 12570272 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | ||||||||
| 125702721 | 12570272 | 12 | C | TENORMIN | ATENOLOL | 1 | Oral | 50 MG, 1X/DAY | 0 | 50 | MG | FILM-COATED TABLET | QD | ||||||
| 125702721 | 12570272 | 13 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | GASTRO-RESISTANT TABLET | QD | ||||||
| 125702721 | 12570272 | 14 | C | SOLUPRED /00016201/ | PREDNISOLONE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 125702721 | 12570272 | 15 | C | FOSRENOL | LANTHANUM CARBONATE | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID | ||||||
| 125702721 | 12570272 | 16 | C | TIORFAN | RACECADOTRIL | 1 | Oral | 100 MG, 3X/DAY (AS NEEDED) | 0 | 100 | MG | CAPSULE | TID | ||||||
| 125702721 | 12570272 | 17 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | 8 MG (4 DF) DAILY (AS NEEDED) | 0 | 8 | MG | CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125702721 | 12570272 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125702721 | 12570272 | Acute kidney injury | |
| 125702721 | 12570272 | Dehydration | |
| 125702721 | 12570272 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125702721 | 12570272 | 1 | 20160128 | 20160213 | 0 | |
| 125702721 | 12570272 | 2 | 201505 | 20160213 | 0 | |
| 125702721 | 12570272 | 3 | 20160128 | 20160213 | 0 | |
| 125702721 | 12570272 | 4 | 20160128 | 20160213 | 0 |